135 related articles for article (PubMed ID: 22277509)
1. [Clinicopathological features of familial amyloid polyneuropathy].
Koike H; Sobue G
Rinsho Shinkeigaku; 2011 Nov; 51(11):1134-7. PubMed ID: 22277509
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of familial amyloid polyneuropathy: wide-ranged clinicopathological features.
Koike H; Sobue G
Expert Opin Med Diagn; 2010 Jul; 4(4):323-31. PubMed ID: 23496148
[TBL] [Abstract][Full Text] [Related]
3. [Familial amyloid polyneuropathy: clinicopathological aspects].
Koike H; Sobue G
Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis.
Koike H; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Tanaka F; Sobue G
Amyloid; 2011 Jun; 18(2):53-62. PubMed ID: 21463231
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathologic and genetic features of early- and late-onset FAP type I (FAP ATTR Val30Met) in Japan.
Sobue G; Koike H; Misu K; Hattori N; Yamamoto M; Ikeda S; Ando Y; Nakazato M; Inukai A
Amyloid; 2003 Aug; 10 Suppl 1():32-8. PubMed ID: 14640040
[TBL] [Abstract][Full Text] [Related]
6. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
[TBL] [Abstract][Full Text] [Related]
7. Late-onset familial amyloid polyneuropathy in Japan.
Koike H; Sobue G
Amyloid; 2012 Jun; 19 Suppl 1():55-7. PubMed ID: 22506939
[TBL] [Abstract][Full Text] [Related]
8. Clinical and pathological studies of cardiac amyloidosis in transthyretin type familial amyloid polyneuropathy.
Hattori T; Takei Y; Koyama J; Nakazato M; Ikeda S
Amyloid; 2003 Dec; 10(4):229-39. PubMed ID: 14986482
[TBL] [Abstract][Full Text] [Related]
9. Late-onset Transthyretin (TTR)-familial Amyloid Polyneuropathy (FAP) with a Long Disease Duration from Non-endemic Areas in Japan.
Miyake Z; Nakamagoe K; Ezawa N; Yoshinaga T; Hashimoto R; Sato T; Sekijima Y; Tamaoka A
Intern Med; 2019 Mar; 58(5):713-718. PubMed ID: 30333406
[TBL] [Abstract][Full Text] [Related]
10. The significance of carpal tunnel syndrome in transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Morozumi S; Kawagashira Y; Iijima M; Yamamoto M; Hattori N; Tanaka F; Nakamura T; Hirayama M; Ando Y; Ikeda S; Sobue G
Amyloid; 2009; 16(3):142-8. PubMed ID: 19626479
[TBL] [Abstract][Full Text] [Related]
11. Late-onset familial amyloid polyneuropathy type I (transthyretin Met30-associated familial amyloid polyneuropathy) unrelated to endemic focus in Japan. Clinicopathological and genetic features.
Misu Ki; Hattori N; Nagamatsu M; Ikeda Si; Ando Y; Nakazato M; Takei Yi; Hanyu N; Usui Y; Tanaka F; Harada T; Inukai A; Hashizume Y; Sobue G
Brain; 1999 Oct; 122 ( Pt 10)():1951-62. PubMed ID: 10506096
[TBL] [Abstract][Full Text] [Related]
12. Upper limb neuropathy such as carpal tunnel syndrome as an initial manifestation of ATTR Val30Met familial amyloid polyneuropathy.
Tojo K; Tsuchiya-Suzuki A; Sekijima Y; Morita H; Sumita N; Ikeda S
Amyloid; 2010 Mar; 17(1):32-5. PubMed ID: 20132088
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of familial amyloid polyneuropathy in Japan: Identification of a novel endemic focus.
Kato-Motozaki Y; Ono K; Shima K; Morinaga A; Machiya T; Nozaki I; Shibata-Hamaguchi A; Furukawa Y; Yanase D; Ishida C; Sakajiri K; Yamada M
J Neurol Sci; 2008 Jul; 270(1-2):133-40. PubMed ID: 18410945
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm.
Sekijima Y; Ueda M; Koike H; Misawa S; Ishii T; Ando Y
Orphanet J Rare Dis; 2018 Jan; 13(1):6. PubMed ID: 29343286
[TBL] [Abstract][Full Text] [Related]
15. Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas.
Koike H; Tanaka F; Hashimoto R; Tomita M; Kawagashira Y; Iijima M; Fujitake J; Kawanami T; Kato T; Yamamoto M; Sobue G
J Neurol Neurosurg Psychiatry; 2012 Feb; 83(2):152-8. PubMed ID: 22228785
[TBL] [Abstract][Full Text] [Related]
16. Transthyretin-related familial amyloid polyneuropathy (ATTR-FAP) in Poland - genetic and clinical presentation.
Lipowska M; Drac H; Rowczenio D; Gilbertson J; Hawkins PN; Lasek-Bal A; Szewczuk J; Grzybowski J; Gawor M; Stępień-Wojno M; Franaszczyk M; Brydak-Godowska J; Śmierciak R; Ptasińska-Perkowska A; Chandoga J; Petrovic R; Kostera-Pruszczyk A
Neurol Neurochir Pol; 2020; 54(6):552-560. PubMed ID: 33373035
[TBL] [Abstract][Full Text] [Related]
17. Elderly onset vitreous opacities as the initial manifestation in hereditary transthyretin (ATTR Val30Met) carries.
Ishida K; Nishida T; Niimi Y; Suemori S; Mochizuki K; Kawakami H; Kimura A; Hirayama T
Ophthalmic Genet; 2017; 38(4):387-391. PubMed ID: 28085522
[TBL] [Abstract][Full Text] [Related]
18. Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy.
Koike H; Nakamura T; Hashizume A; Nishi R; Ikeda S; Kawagashira Y; Iijima M; Katsuno M; Sobue G
J Neurol; 2017 Nov; 264(11):2293-2302. PubMed ID: 28983659
[TBL] [Abstract][Full Text] [Related]
19. Transthyretin-related vitreous amyloidosis in different endemic areas.
Kawaji T; Ando Y; Ando E; Sandgren O; Suhr OB; Tanihara H
Amyloid; 2010 Sep; 17(3-4):105-8. PubMed ID: 21077797
[TBL] [Abstract][Full Text] [Related]
20. Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity.
Ikeda S; Nakazato M; Ando Y; Sobue G
Neurology; 2002 Apr; 58(7):1001-7. PubMed ID: 11940682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
